{
  "id": "nclex_ngn_mcq_mission_500_114",
  "seed": "MISSION-500-114-1771349458751",
  "questionType": "multipleChoice",
  "difficulty": "Level 4-5 (Highly Discriminating)",
  "domain": "Safe and Effective Care Environment",
  "subDomain": "Safety and Infection Control",
  "topic": "Lithium Toxicity",
  "questionText": "The nurse is preparing to administer the 1800 (6:00 PM) medications for a client admitted with confusion. Based on the client's electronic health record, which action is most appropriate for the nurse to take?",
  "tabs": [
    {
      "id": "tab1",
      "label": "Nurses' Notes",
      "content": [
        {
          "type": "note",
          "time": "1630 (4:30 PM)",
          "author": "RN",
          "text": "Client is alert but oriented only to person. Speech is slurred. Exhibits coarse bilateral hand tremors and a shuffling, unsteady gait (ataxia) when ambulating to the bathroom. Daughter at bedside states the client was started on 'a new blood pressure pill' by his primary care provider about one week ago. Daughter also expresses concern, stating, 'Dad lives alone on a fixed income and sometimes misses his appointments because it's hard to get a ride.'"
        }
      ]
    },
    {
      "id": "tab2",
      "label": "Vital Signs",
      "content": [
        {
          "type": "table",
          "header": [
            "Time",
            "BP",
            "HR",
            "RR",
            "Temp (Â°F)",
            "SpO2 (%)"
          ],
          "rows": [
            [
              "0800 (8:00 AM)",
              "118/74",
              "88",
              "18",
              "98.6",
              "96"
            ],
            [
              "1200 (12:00 PM)",
              "106/68",
              "96",
              "18",
              "98.8",
              "95"
            ],
            [
              "1600 (4:00 PM)",
              "98/60",
              "104",
              "20",
              "99.0",
              "95"
            ]
          ]
        }
      ]
    },
    {
      "id": "tab3",
      "label": "Laboratory Results",
      "content": [
        {
          "type": "table",
          "header": [
            "Test",
            "Result",
            "Reference Range"
          ],
          "rows": [
            [
              "Lithium",
              "2.1 mEq/L",
              "0.6-1.2 mEq/L"
            ],
            [
              "Sodium",
              "132 mEq/L",
              "136-145 mEq/L"
            ],
            [
              "Potassium",
              "4.1 mEq/L",
              "3.5-5.0 mEq/L"
            ],
            [
              "BUN",
              "45 mg/dL",
              "10-20 mg/dL"
            ],
            [
              "Creatinine",
              "2.2 mg/dL",
              "0.6-1.2 mg/dL"
            ]
          ]
        }
      ]
    },
    {
      "id": "tab4",
      "label": "Diagnostic Findings",
      "content": [
        {
          "type": "report",
          "title": "ECG Interpretation",
          "body": "Rhythm: Sinus tachycardia. Rate: 104 bpm. Findings: Flattened T-waves and a prolonged QTc interval of 510 ms. No acute ischemic changes noted."
        }
      ]
    },
    {
      "id": "tab5",
      "label": "MAR",
      "content": [
        {
          "type": "medication",
          "name": "Lithium Carbonate",
          "dose": "300 mg",
          "route": "PO",
          "frequency": "Twice Daily",
          "lastGiven": "0900 (9:00 AM)",
          "nextDue": "1800 (6:00 PM)",
          "status": "Scheduled"
        },
        {
          "type": "medication",
          "name": "Lisinopril",
          "dose": "10 mg",
          "route": "PO",
          "frequency": "Daily",
          "lastGiven": "0900 (9:00 AM)",
          "nextDue": "Tomorrow 0900 (9:00 AM)",
          "status": "Administered"
        },
        {
          "type": "medication",
          "name": "Acetaminophen",
          "dose": "650 mg",
          "route": "PO",
          "frequency": "Every 6 hours PRN Pain",
          "lastGiven": null,
          "nextDue": null,
          "status": "Available"
        }
      ]
    }
  ],
  "options": [
    {
      "id": "opt4",
      "text": "Administer 1 L of 0.9% sodium chloride and re-evaluate the client's blood pressure in one hour."
    },
    {
      "id": "opt2",
      "text": "Withhold the scheduled dose of lithium carbonate and notify the healthcare provider immediately."
    },
    {
      "id": "opt3",
      "text": "Request a neurology consult to evaluate the client's new-onset ataxia and confusion."
    },
    {
      "id": "opt1",
      "text": "Administer the scheduled dose of lithium carbonate and document the client's tremor severity."
    }
  ],
  "correctAnswerId": "opt2",
  "answerBreakdown": {
    "opt1": {
      "isCorrect": false,
      "rationale": "Incorrect. Administering lithium would exacerbate the client's already toxic lithium levels. Lithium toxicity occurs when lithium accumulates in the body, exceeding the therapeutic range (0.6-1.2 mEq/L). This can happen due to impaired renal function, dehydration, or drug interactions. In this case, the client's elevated BUN and creatinine indicate kidney injury, reducing lithium clearance. Lisinopril, an ACE inhibitor, further impairs lithium excretion by reducing glomerular filtration. The resulting toxic levels disrupt neuronal function, leading to neurological symptoms like confusion, slurred speech, and ataxia. Cardiac effects include altered repolarization (flattened T waves, prolonged QTc). Administering more lithium would worsen these effects, potentially leading to seizures, coma, and cardiac arrhythmias.",
      "scoring": "+/-"
    },
    "opt2": {
      "isCorrect": true,
      "rationale": "Correct. The client exhibits signs of severe lithium toxicity: a toxic serum level (2.1 mEq/L), neurological symptoms (confusion, ataxia, slurred speech, coarse tremors), renal impairment (BUN 45 mg/dL, Creatinine 2.2 mg/dL), and cardiotoxicity (prolonged QTc interval of 510 ms, sinus tachycardia). Lithium toxicity occurs because lithium is primarily excreted by the kidneys, and any factor that reduces renal function can lead to accumulation. ACE inhibitors like lisinopril reduce glomerular filtration pressure, decreasing lithium clearance. The combination of impaired renal function and lisinopril likely precipitated this toxicity. Withholding the lithium is the priority to prevent further absorption and worsening of symptoms. Notifying the healthcare provider is essential for initiating emergency interventions, including IV fluids for hydration and electrolyte balance, and potentially hemodialysis to remove lithium from the bloodstream.",
      "scoring": "+/-"
    },
    "opt3": {
      "isCorrect": false,
      "rationale": "Incorrect. While neurological symptoms are present, the clinical picture strongly suggests lithium toxicity as the underlying cause. Lithium toxicity directly affects the central nervous system, disrupting neurotransmitter function and neuronal excitability. This leads to the observed neurological manifestations. While a neurology consult might be considered later, the immediate priority is to address the lithium toxicity. Delaying treatment to obtain a consult could result in irreversible neurological damage. Addressing the underlying cause (lithium toxicity) is paramount before considering other potential neurological etiologies.",
      "scoring": "+/-"
    },
    "opt4": {
      "isCorrect": false,
      "rationale": "Incorrect. While IV fluids are a crucial component of treating lithium toxicity, they are not the immediate first action. Lithium toxicity often leads to dehydration due to vomiting and diarrhea, further impairing renal function and exacerbating lithium retention. IV fluids help to restore intravascular volume, improve renal perfusion, and promote lithium excretion. However, administering fluids without first withholding the lithium dose is an incomplete and potentially dangerous action. The priority is to stop further absorption of lithium by withholding the medication.",
      "scoring": "+/-"
    }
  },
  "clinicalPearls": [
    "Lithium toxicity can be life-threatening and presents with neurological (tremors, ataxia, confusion), renal (elevated BUN/Creatinine), and cardiac (ECG changes) manifestations.",
    "ACE inhibitors (like lisinopril) can significantly increase lithium levels by reducing renal clearance. Monitor lithium levels closely when starting or adjusting ACE inhibitors in clients taking lithium.",
    "Early recognition and intervention are crucial in managing lithium toxicity to prevent severe complications like seizures, coma, and cardiac arrhythmias.",
    "Assess for medication interactions, especially in older adults with multiple comorbidities and polypharmacy.",
    "Hydration is a key component of treating lithium toxicity, but withholding the medication is the immediate priority.",
    "Dialysis may be necessary in severe cases of lithium toxicity to rapidly remove lithium from the body."
  ],
  "sbar": {
    "situation": "The client, admitted with confusion, is scheduled to receive their 1800 (6:00 PM) medications.",
    "background": "The client is alert but oriented only to person, exhibiting slurred speech, coarse bilateral hand tremors, and ataxia. The daughter reports the client started lisinopril a week ago and has difficulty attending appointments. Lab results show lithium 2.1 mEq/L, sodium 132 mEq/L, BUN 45 mg/dL, and creatinine 2.2 mg/dL. ECG shows sinus tachycardia, flattened T-waves, and prolonged QTc interval of 510 ms.",
    "assessment": "The client is exhibiting signs and symptoms of severe lithium toxicity, likely exacerbated by lisinopril-induced reduction in lithium clearance, and acute kidney injury.",
    "recommendation": "Withhold the scheduled 1800 (6:00 PM) dose of lithium carbonate immediately and notify the healthcare provider for further orders. The client requires aggressive hydration and possible hemodialysis. Monitor vital signs and neurological status closely."
  },
  "sentinelStatus": "healed_v2026_v8"
}